Prognostic factors of survival in patients with lung cancer after low-dose computed tomography screening: a multivariate analysis of a lung cancer screening cohort in China

  • 0Department of Non-Communicable Diseases Prevention and Control, Shanghai Minhang Center for Disease Control and Prevention, Shanghai, 201101, China.

|

|

Summary

This summary is machine-generated.

This study identified key prognostic factors for lung cancer survival in a community screening cohort. Factors like gender, age, income, and nodule characteristics significantly impact patient outcomes.

Area Of Science

  • Oncology
  • Public Health
  • Radiology

Background

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Early detection through low-dose computed tomography (LDCT) screening improves survival rates.
  • Identifying prognostic factors is crucial for personalized lung cancer management.

Purpose Of The Study

  • To evaluate prognostic factors influencing lung cancer patient survival.
  • To analyze data from a community-based lung cancer screening cohort.
  • To identify predictors of survival for early-stage lung cancer.

Main Methods

  • Population-based prospective cohort study of 25,310 participants (2013-2017).
  • Kaplan-Meier and log-rank tests for survival analysis.
  • Cox proportional hazards regression models to identify prognostic factors including demographics, risk factors, LDCT findings, and treatment.

Main Results

  • 429 lung cancer cases were identified; 1, 3, and 5-year survival rates were 74.4%, 59.4%, and 54.5%.
  • Multivariate analysis revealed significant prognostic factors: male gender, older age, lower income, small cell carcinoma, advanced stage, and lack of surgery.
  • LDCT screening model indicated solid and larger nodules were associated with worse prognosis.

Conclusions

  • Key prognostic factors for lung cancer detected via LDCT screening have been identified.
  • These findings can assist clinicians in treatment decision-making for lung cancer patients.
  • Further research with larger cohorts and detailed follow-up is recommended for enhanced prognostic prediction.